Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Distinct properties of layer 3 pyramidal neurons from prefrontal and parietal areas of the monkey neocortex.

Gonzalez-Burgos G, Miyamae T, Krimer Y, Gulchina Y, Pafundo DE, Krimer O, Bazmi H, Arion D, Enwright JF, Fish K, Lewis DA.

J Neurosci. 2019 Jul 24. pii: 1210-19. doi: 10.1523/JNEUROSCI.1210-19.2019. [Epub ahead of print]

PMID:
31341029
2.

Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders.

Chung DW, Chung Y, Bazmi HH, Lewis DA.

Neuropsychopharmacology. 2018 Nov;43(12):2478-2486. doi: 10.1038/s41386-018-0169-7. Epub 2018 Aug 2.

PMID:
30120408
3.

Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia.

Hoftman GD, Dienel SJ, Bazmi HH, Zhang Y, Chen K, Lewis DA.

Biol Psychiatry. 2018 Apr 15;83(8):670-679. doi: 10.1016/j.biopsych.2017.11.029. Epub 2017 Dec 7.

4.

Development of transcripts regulating dendritic spines in layer 3 pyramidal cells of the monkey prefrontal cortex: Implications for the pathogenesis of schizophrenia.

Dienel SJ, Bazmi HH, Lewis DA.

Neurobiol Dis. 2017 Sep;105:132-141. doi: 10.1016/j.nbd.2017.05.016. Epub 2017 May 31.

5.

Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients.

Mansouri N, Movafagh A, Sayad A, Heidary Pour A, Taheri M, Soleimani S, Mirzaei HR, Alizadeh Shargh S, Azargashb E, Bazmi H, Allah Moradi H, Zandnia F, Hashemi M, Massoudi N, Mortazavi-Tabatabaei SA.

Asian Pac J Cancer Prev. 2016;17(S3):317-21.

6.

Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.

Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA.

Schizophr Bull. 2016 Mar;42(2):396-405. doi: 10.1093/schbul/sbv139. Epub 2015 Sep 30.

7.

Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.

Kimoto S, Zaki MM, Bazmi HH, Lewis DA.

JAMA Psychiatry. 2015 Aug;72(8):747-56. doi: 10.1001/jamapsychiatry.2015.0533.

8.

Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268.

Kimoto S, Bazmi HH, Lewis DA.

Am J Psychiatry. 2014 Sep;171(9):969-78. doi: 10.1176/appi.ajp.2014.14010004.

9.

Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.

Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA.

Schizophr Bull. 2015 Jan;41(1):180-91. doi: 10.1093/schbul/sbt178. Epub 2013 Dec 22.

10.

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.

Barnas D, Koontz D, Bazmi H, Bixby C, Jemsek J, Mellors JW.

Antivir Ther. 2010;15(3):437-41. doi: 10.3851/IMP1539.

11.

Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA.

Am J Psychiatry. 2008 Apr;165(4):479-89. doi: 10.1176/appi.ajp.2007.07081223. Epub 2008 Feb 15.

12.

In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.

Hammond JL, Parikh UM, Koontz DL, Schlueter-Wirtz S, Chu CK, Bazmi HZ, Schinazi RF, Mellors JW.

Antimicrob Agents Chemother. 2005 Sep;49(9):3930-2.

13.

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT Jr, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM.

J Clin Microbiol. 2005 Jan;43(1):406-13.

14.

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.

Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM.

J Clin Microbiol. 2003 Oct;41(10):4531-6.

15.
16.

DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.

Schinazi RF, Mellors J, Bazmi H, Diamond S, Garber S, Gallagher K, Geleziunas R, Klabe R, Pierce M, Rayner M, Wu JT, Zhang H, Hammond J, Bacheler L, Manion DJ, Otto MJ, Stuyver L, Trainor G, Liotta DC, Erickson-Viitanen S.

Antimicrob Agents Chemother. 2002 May;46(5):1394-401.

17.

Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.

Hammond JL, Koontz DL, Bazmi HZ, Beadle JR, Hostetler SE, Kini GD, Aldern KA, Richman DD, Hostetler KY, Mellors JW.

Antimicrob Agents Chemother. 2001 Jun;45(6):1621-8.

19.

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Lyles RH, Muñoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW.

J Infect Dis. 2000 Mar;181(3):872-80.

PMID:
10720507
20.

Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate.

Tramontano E, Piras G, Mellors JW, Putzolu M, Bazmi HZ, La Colla P.

Biochem Pharmacol. 1998 Dec 15;56(12):1583-9.

PMID:
9973178
21.

Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1.

Tachedjian G, Mellors JW, Bazmi H, Mills J.

AIDS Res Hum Retroviruses. 1998 Aug 10;14(12):1059-64.

PMID:
9718121
22.
23.

Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

Tachedjian G, Hooker DJ, Gurusinghe AD, Bazmi H, Deacon NJ, Mellors J, Birch C, Mills J.

Virology. 1995 Sep 10;212(1):58-68.

24.

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.

Mellors JW, Bazmi HZ, Schinazi RF, Roy BM, Hsiou Y, Arnold E, Weir J, Mayers DL.

Antimicrob Agents Chemother. 1995 May;39(5):1087-92.

25.

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.

Schinazi RF, Lloyd RM Jr, Nguyen MH, Cannon DL, McMillan A, Ilksoy N, Chu CK, Liotta DC, Bazmi HZ, Mellors JW.

Antimicrob Agents Chemother. 1993 Apr;37(4):875-81.

26.

Supplemental Content

Support Center